Loading clinical trials...

RECRUITINGNA

Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis

A Multicenter Randomized Controlled Trial of Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis

NCT06231264•Xijing Hospital

View on ClinicalTrials.gov

Summary

The aim of this study was to evaluate the efficacy and safety of transcutaneous electrical acustimulation in patients with mild to moderate ulcerative colitis.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Age ≥18 years
•2. Ulcerative colitis diagnosed for at least 3 mouths.
•3. Mayo score 4-10, Mayo endoscopic score 2-3 points
•4. Resistant to at least one type of medical treatments

Exclusion Criteria

•1. Treatment-naive ulcerative colitis (no previous treatment)
•2. Acute severe ulcerative colitis
•3. Previous surgical treatment or severe colitis at imminent risk of surgery infective colitis
•4. Other systemic diseases
•5. Pregnancy and lactation
•6. Allergic to the electrode patch

Locations (4)

Honghui hospital

Xi'an, Shaanxi, China

Second Affiliated Hospital of Xi 'an Jiaotong University

Xi'an, Shaanxi, China

Tangdu Hospital

Xi'an, Shaanxi, China

Xijing Hospital

Xi'an, Shaanxi, China

Key Dates

Start Date

January 19, 2024

Primary Completion Date

March 1, 2026

Completion Date

May 1, 2026

Last Updated

May 25, 2025

Enrollment

ESTIMATED participants

Conditions

Ulcerative Colitis

Interventions

transcutaneous electrical acustimulation at treatment sites

DEVICE

transcutaneous electrical acustimulation at sham sites

DEVICE

Contacts

Jian Wan

CONTACT

+8615529202305 408127528@qq.com

Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis

NCT07271069

Ulcerative Colitis (UC)

View study

RECRUITINGPHASE2

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

NCT06975722

Ulcerative Colitis

View study

RECRUITINGPHASE3

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 25, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis

Inclusion Criteria

Exclusion Criteria

Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects